Takeda Pharmaceutical Company Limited (TAK) Fiscal Year 2023 Earnings Call Transcript Summary

The following is a summary of the Takeda Pharmaceutical Company Limited (TAK) Fiscal Year 2023 Earnings Call Transcript:Financial Performance:Takeda Pharmaceutical reported a 5.9% revenue growth of ov

moomoo AI43minutes ago · Conference Call

NIKKEI 225 Index Flat at This Week to 38229.11 -- Data Talk

The NIKKEI 225 Index is down 6.96 points or 0.02% this week to 38229.11 --Largest one-week point and percentage decline since the week ending April 19, 2024 --Snaps a two-week winning streak --Toda

Dow Jones06:48 ET

Pursue high-growth companies! Fiscal Year Ending 25/3 [Increase in Sales and Profit] List ＜Special Feature on Growth Stocks＞ 5/10 Edition

As financial results announcements for the fiscal year ending March 31, '24 are in full swing, market attention is focused on the earnings forecast for the fiscal year ending 25/3, which will be announced at the same time. Demand for semiconductors is expected to recover this fiscal year, and it seems that there are many views that the upward trend in profit will continue, as domestic demand-related expansion is also expected against the backdrop of the penetration of price increases and an increase in inbound consumption due to depreciation of the yen. There is also growing interest in movements to strengthen shareholder returns aimed at improving capital efficiency. Increase for the fiscal year ending 25/3 from the financial results announced today in this special issue

Minkabu06:00 ET

Towards next week's stock exchange rate = attention will be drawn to the US CPI, but will it continue to move forward and backward

The Nikkei Stock Average on the 10th rebounded for the first time in 3 days, and closed 155 yen higher than the previous day. It rose by over 600 yen at one point, but growth was sluggish thereafter. This day was said to be “bought with futures and sold with futures” (market participants), and there was a slight lack of direction. I was present for 4 days this week after Golden Week, but it was almost flat at 7 yen depreciation on a weekly basis. The upper price of the Nikkei Stock Average has been held at the 25-day moving average (around 38,550 yen), and the increase is heavy.

Minkabu04:19 ET

After a round of buying, there was a heavy increase in price due to holding adjustments, sales, etc.

The Nikkei Average rebounded for the first time in 3 days. The transaction closed at 38229.11 yen (estimated turnover of 2.32 billion shares), which rose by 155.13 yen. The rise in major stock price indices in the US market the day before was well received, and buying took precedence over a wide range of stocks. The increase in the Nikkei Average widened over the middle of the front market, and rose to 38741.88 yen. However, since it exceeded 38600 yen on the 25th line level, which was seen as an imminent increase in price, sales to secure profit came out, and weekend holding adjustment sales, next week

Fisco Japan03:02 ET

Backstage [stocks that moved, stocks that were made]

*Sega Sammy HD ＜6460＞ 2186 +101.5 stock buyback announcement with an upper limit of 3.24% of the number of issued shares. *Daido Steel ＜5471＞ net profit (IFRS) forecast of 33 billion yen for the fiscal year ending 1626 -10525. The fiscal year ended March 24 (Japanese standard) was 49.7 billion yen. *NTT ＜9432＞ 162.3 -5.625 operating profit forecast to decrease 5.9%. *Sun Wells ＜9229＞ 2730 +462 newly launched home-visit nursing business, operating profit forecast for the current fiscal year is 39.2

Fisco Japan02:45 ET